Abstract
Background More than half of the world’s population have been infected with H. pylori, however the relationship between H. pylori infection and coronary heart disease (CHD) is unknown.
Methods This study used mendelian randomization (MR) analyses. The instrument variables for H. pylori infection were genetic variables (rs10004195 and rs368433) obtained from a published study. The outcome data included diagnosis, prognosis, and pathogenesis data for CHD, which were extracted from the public genome-wide association studies database, mainly from the CARDIoGRAMplusC4D consortium, UK Biobank, IEU database, and FinnGen database. MR analyses were performed per outcome database and were conducted by reverse analysis. Two step MR analyses were used to explore indirect pathogenic factors of H. pylori infection.
Results Genetically-predicted H. pylori infection was causally associated with body mass index (BMI) (β, 0.022; 95% CI, 0.008–0.036; p-value = 0.001), but not with the diagnosis of CHD (OR, 0.991; 95%CI, 0.904–1.078; p-value = 0.842, IEU database; OR, 1.049; 95% CI, 0.980–1.118; p-value = 0.178, FinnGen database) and prognosis of CHD (OR, 0.999; 95% CI, 0.997–1.001; p-value = 0.391, IEU database; OR, 1.022; 95% CI, 0.922–1.123; p-value = 0.663, FinnGen database). The causal effect of H. pylori infection on CHD is mediated by BMI. Inverse MR showed no causal effect of CHD on H. pylori infection.
Conclusions Our findings confirm the causal effect of H. pylori infection on CHD is mediated by BMI. Eradication or prevention of H. pylori infection may have a clinical benefit for patients with CHD indirectly.
What Is New?
Genetically-predicted H. pylori infection was causally associated with body mass index, but not with the diagnosis and prognosis (major adverse cardiovascular events) of coronary heart disease.
The causal effect of H. pylori infection on coronary heart disease is mediated by body mass index. Inverse mendelian randomization analyses showed no causal effect of coronary heart disease on H. pylori infection.
What Are the Clinical Implications?
Our findings confirm that the causal effect of H. pylori infection on coronary heart disease is partially mediated by body mass index.
Eradication or prevention of H. pylori infection may have a clinical benefit for patients with CHD indirectly.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No new approval was required.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The datasets presented in this study can be downloaded from the public website (Table 1)
Nonstandard Abbreviations and Acronyms
- CHD
- coronary heart disease
- GWAS
- genome-wide association studies
- H. pylori
- helicobacter pylori
- IVs
- instrument variables
- IVW
- inverse variance weighted
- MACE
- major adverse cardiovascular events
- MR
- mendelian randomization
- SNPs
- single nucleotide polymorphisms
